GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » Loans Receivable

BRGX (BioRegenx) Loans Receivable : $0.00 Mil (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is BioRegenx Loans Receivable?

BioRegenx's Loans Receivable for the quarter that ended in Sep. 2024 was $0.00 Mil.


BioRegenx Loans Receivable Historical Data

The historical data trend for BioRegenx's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRegenx Loans Receivable Chart

BioRegenx Annual Data
Trend Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioRegenx Quarterly Data
Dec04 Mar05 Jun05 Sep05 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BioRegenx Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


BioRegenx Loans Receivable Related Terms

Thank you for viewing the detailed overview of BioRegenx's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


BioRegenx Business Description

Traded in Other Exchanges
N/A
Address
7407 Ziegler Road, Chattanooga, TN, USA, 37421
BioRegenx Inc is redefining health intelligence with new patented technologies and artificial intelligence. Its specialize in developing intellectual property (IP) and are engaged in regenerative biotherapeutics, anti-aging, artificial intelligence (AI) for healthcare and bioinformatics for public and private transportation. The primary focus involves acquiring or developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing extensive datasets.

BioRegenx Headlines

From GuruFocus

Findit Inc Announces Investor Update

By ACCESSWIRE ACCESSWIRE 07-29-2022